76 related articles for article (PubMed ID: 3296604)
1. [In vitro purification of autologous bone marrow for removal of neoplastic and leukemic cells].
Sułek K; Kłos M
Acta Haematol Pol; 1986; 17(3-4):154-60. PubMed ID: 3296604
[No Abstract] [Full Text] [Related]
2. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
3. Sensitive detection of metastatic tumor cells in bone marrow.
Moss TJ
Prog Clin Biol Res; 1994; 389():567-77. PubMed ID: 7700922
[No Abstract] [Full Text] [Related]
4. Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue.
Vaughan WP; Weisenburger DD; Sanger W; Gale RP; Armitage JO
Bone Marrow Transplant; 1987 Apr; 1(4):373-8. PubMed ID: 3332145
[TBL] [Abstract][Full Text] [Related]
5. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies and magnetic microspheres for the depletion of leukaemic cells from bone marrow harvested for autologous transplantation.
Kemshead JT; Treleaven J; Heath L; Meara AO; Gee A; Ugelstad J
Bone Marrow Transplant; 1987 Aug; 2(2):133-9. PubMed ID: 3332162
[TBL] [Abstract][Full Text] [Related]
8. The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemia.
Testa NG; Coutinho L; Chang J; Morgenstern G; Scarffe JH; Dexter TM
Haematol Blood Transfus; 1987; 31():75-8. PubMed ID: 3327789
[No Abstract] [Full Text] [Related]
9. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
Geller RB
Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
[TBL] [Abstract][Full Text] [Related]
10. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
11. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemias.
Favrot MC; Hervé P
Bone Marrow Transplant; 1987 Aug; 2(2):117-22. PubMed ID: 3502784
[TBL] [Abstract][Full Text] [Related]
13. Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia.
Beaujean F; Bernaudin F; Kuentz M; Lemerle S; Cordonnier C; Le Forestier C; Reinert P; Duedari N; Brandely M; Vernant JP
Bone Marrow Transplant; 1995 May; 15(5):691-6. PubMed ID: 7670397
[TBL] [Abstract][Full Text] [Related]
14. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
15. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
16. Autologous marrow transplantation and the extracorporeal separability of normal and leukemic cells.
Wheldon TE
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):753-4. PubMed ID: 361659
[No Abstract] [Full Text] [Related]
17. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
[TBL] [Abstract][Full Text] [Related]
18. [Autologous bone marrow grafts and solid tumors].
Beaulieu R
Union Med Can; 1983 May; 112(5):450-2, 460. PubMed ID: 6349082
[No Abstract] [Full Text] [Related]
19. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960
[TBL] [Abstract][Full Text] [Related]
20. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
